TY  - RPRT
TI  - Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages
AU  - Wang, Q.
AU  - Guo, Y.
AU  - Ho, J.
AU  - Ho, D. D.
PY  - 2024
DO  - 10.1101/2024.08.12.607496
UR  - https://www.biorxiv.org/content/10.1101/2024.08.12.607496v1
ID  - 10.1101/2024.08.12.607496
ER  -